Sorrento Therapeutics, Inc.
SRNEDelisted Apr 12, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000850261
Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Sorrento Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 5 | 4 | −1 |
| Shares | 110.4K | 100.5K | −9.88K (−9.0%) |
| Value | $826 | $287 | −$539 (−65.3%) |
New holders (1)
Institutions that held Sorrento Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighPoint Advisor Group LLC | 22,250 | $60 | 0.00% |
Sold out (2)
Institutions that held Sorrento Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| KLCM Advisors, Inc. | 30,000 | $285 |
| AlphaMark Advisors, LLC | 2,135 | $0 |